Joshua Gertsman

Verified

Managing Director of Aditum Bio GP 3, LLC at Aditum Bio ManagementListed on SEC Form ADVOakland, United States

Claim this profile

Cold

Check Size

Not yet known

Reliability Score

🎯100% of deals in Healthcare

Investment Timeline

Tempero Bio

Board seat (SEC Form D)Source

Since Nov 2025

Company last raised Nov 2025

Portfolio Breakdown

By Sector

Healthcare1 deal · 100%

By Stage

1 tracked deal1 sector · 0 stages

Deal Velocity

Avg Deals / Year

1.0

Avg Deal Size

Unknown

Largest Deal

Tempero Bio

Unknown

YoY Trend

Steady

Deals Per Year

1 total deal tracked2025–2025

Investment Activity Map

Jan

Feb

Mar

Apr

May

Jun

Jul

Aug

Sep

Oct

Nov

Dec

2025

Less

Current Fund Status

Fund Name

Aditum Bio Fund 2, L.P.

Reported Size

$179.6M

Co-Investors

No co-investment data available yet.